Evidence map›Paper›PMID 40999613›Full record

ReviewCurrent drug targets2026

Proteasome Fine-Tunes the Generation of Antimicrobial Peptides.

Anita Kovalaske, Ian McLauchlan, Megan Murphy, Hope Omoniyi, Grace Hohman, Mohamed Eldeeb

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current drug targets, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Anita KovalaskeDepartment of Chemistry, Illinois State University, Normal, IL, USA.
Ian McLauchlanDepartment of Chemistry, Illinois State University, Normal, IL, USA.
Megan MurphyDepartment of Chemistry, Illinois State University, Normal, IL, USA.
Hope OmoniyiDepartment of Chemistry, Illinois State University, Normal, IL, USA.
Grace HohmanDepartment of Chemistry, Illinois State University, Normal, IL, USA.
Mohamed EldeebDepartment of Chemistry, Illinois State University, Normal, IL, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial peptides (AMPs), part of the body's innate immune response, are natural compounds that inhibit bacteria during bacterial infections. Despite their important role in counteracting cellular pathogens, the precise mechanism of generating AMPs in response to bacterial infection remains elusive. However, recent findings demonstrate that the proteasome, a cellular complex involved in the degradation of intracellular proteins, plays a key role in generating AMPs during bacterial infection. Intriguingly, bacterial infections have been shown to mediate the remodeling of the proteasome, resulting in altered cleavage activity that increases the generation of antimicrobial peptides and helps reduce intracellular bacterial load. Additionally, the 11S proteasome subunit PSME3 has been identified as the key regulatory particle responsible for triggering proteasome remodeling in response to bacterial stress. Remarkably, given the burgeoning research on antimicrobial agents, the recent findings uncover an important anti-bacterial functional role of the proteasome and open avenues for investigating strategies to modulate or enhance the cell's natural defense against pathogens to develop new antimicrobial therapeutics.

Indexed as

Anti-Bacterial AgentsAntimicrobial PeptidesBacterial InfectionsProteasome Endopeptidase ComplexAnimalsBacteriaHumansImmunity, InnateProteolysisAnti-Bacterial AgentsAntimicrobial PeptidesProteasome Endopeptidase Complexantimicrobial peptidesinnate immunityproteasomeproteasome-derived defense peptidesproteasome remodelingProtein degradationproteolysis

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.